About PharmAla Biotech
PharmAla Biotech is a company based in Toronto (Canada) founded in 2021.. PharmAla Biotech offers products and services including LaNeo™ MDMA and Novel MDXX Compounds. PharmAla Biotech operates in a competitive market with competitors including MCRA, Blue Matter Consulting, CHDR, S-Cubed and CATALIS, among others.
- Headquarter Toronto, Canada
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pharmala Biotech Holdings, Inc.
-
Annual Revenue
$722.82 K (USD)94.6as on Aug 31, 2024
-
Net Profit
$-572.42 K (USD)-5.61as on Aug 31, 2024
-
EBITDA
$-414.21 K (USD)18.03as on Aug 31, 2024
-
Latest Funding Round
$1.09 M (USD), Post-IPO
Dec 20, 2024
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of PharmAla Biotech
PharmAla Biotech is a publicly listed company on the CSE with ticker symbol MDMA in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of PharmAla Biotech
PharmAla Biotech offers a comprehensive portfolio of products and services, including LaNeo™ MDMA and Novel MDXX Compounds. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Clinical-grade MDMA for research and therapeutic applications.
Improved MDMA analogs to enhance safety for various disorders.
Funding Insights of PharmAla Biotech
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $1.1M
- First Round First Round
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Post-IPO - PharmAla Biotech | Valuation |
investors |
|
| Apr, 2024 | Amount | Post-IPO - PharmAla Biotech | Valuation |
investors |
|
| Jun, 2023 | Amount | Post-IPO - PharmAla Biotech | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by PharmAla Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PharmAla Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pharmala Biotech Comparisons
Competitors of PharmAla Biotech
PharmAla Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MCRA, Blue Matter Consulting, CHDR, S-Cubed and CATALIS, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of regulatory, quality assurance and market access services to biopharma sector
|
|
| domain | founded_year | HQ Location |
Provider of consulting services focused for clinical drug development
|
|
| domain | founded_year | HQ Location |
Early-stage clinical drug research consulting services are provided.
|
|
| domain | founded_year | HQ Location |
Specialized consulting in clinical biometrics and regulatory affairs is provided.
|
|
| domain | founded_year | HQ Location |
Consulting services for clinical drug development and trials are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pharmala Biotech
Frequently Asked Questions about PharmAla Biotech
When was PharmAla Biotech founded?
PharmAla Biotech was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Where is PharmAla Biotech located?
PharmAla Biotech is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
What is the annual revenue of PharmAla Biotech?
Annual revenue of PharmAla Biotech is $722.82K as on Aug 31, 2024.
What does PharmAla Biotech do?
PharmAla Biotech was founded in 2021 and is based in Toronto, Canada. Operations focus on the biotechnology sector, where biomanufacturing processes are supported alongside regulatory compliance and financial advisory services. These offerings assist clients in navigating production, approval, and funding challenges within the industry. The companys domain, pharmala.ca, serves as the primary online presence for these activities.
Who are the top competitors of PharmAla Biotech?
PharmAla Biotech's top competitors include S-Cubed, Vasta Global and Blue Matter Consulting.
What products or services does PharmAla Biotech offer?
PharmAla Biotech offers LaNeo™ MDMA and Novel MDXX Compounds.
Is PharmAla Biotech publicly traded?
Yes, PharmAla Biotech is publicly traded on CSE under the ticker symbol MDMA.
What is PharmAla Biotech's ticker symbol?
The ticker symbol of PharmAla Biotech is MDMA on CSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.